News &amp; Updates

Autologous breast reconstruction achieves comparable operative time and rate of surgical procedures as implant-based reconstructions, a recent study has found. However, medium-term costs are much higher for autologous operations.

Autologous more expensive than implant-based breast reconstruction in medium term

SSRIs may protect against noncardioembolic ischaemic stroke

Use of selective serotonin reuptake inhibitors (SSRIs) poses no risk of noncardioembolic ischaemic stroke and is even protective when compared with other antidepressants, according to a recent study.

SSRIs may protect against noncardioembolic ischaemic stroke

Appendicolith ups appendectomy risk after antibiotic treatment for acute appendicitis

The presence of appendicolith is tied to an almost twofold risk of requiring an appendectomy within 30 days in patients who initially received antibiotic therapy for acute uncomplicated appendicitis, according to an analysis of the CODA* study from the US.

Appendicolith ups appendectomy risk after antibiotic treatment for acute appendicitis

Rivaroxaban slows renal decline in NVAF patients

Compared with warfarin, rivaroxaban lowers the risk and rate of renal decline in patients with nonvalvular atrial fibrillation (NVAF), a new study reports.

Rivaroxaban slows renal decline in NVAF patients

Probiotic use in IBD: Yay or nay?

Using the probiotic Escherichia coli Nissle 1917 (EcN) as add-on therapy for patients with mild-to-moderate ulcerative colitis (UC) helps induce disease remission and preserve quality of life (QoL) in these patients, according to studies presented at CCC 2022.

Probiotic use in IBD: Yay or nay?

At-home COVID-19 antigen self-tests reliable, user acceptable, safe

Self-performed rapid antigen detection tests (RADTs) are feasible and acceptable among laypeople, with the tests yielding higher sensitivities in the presence of symptoms and most individuals expressing preference for the at-home tests over a professionally administered nasopharyngeal RADT, as reported in a study.

At-home COVID-19 antigen self-tests reliable, user acceptable, safe

Pandemic fuels mental distress, gastric problems in IBS patients with anxiety/depression

The COVID-19 pandemic has contributed to self-reported increases in psychological distress and gastrointestinal symptoms among individuals with irritable bowel syndrome (IBS) and comorbid anxiety and/or depression, reveals a study.

Pandemic fuels mental distress, gastric problems in IBS patients with anxiety/depression

08 Feb 2022

Waist-height ratio predicts severe diabetic eye disease risk in T1D

Waist-height ratio (WHtR), a hallmark of central obesity, appears to be a good indicator for the risk of developing severe diabetic eye disease (SDED) in adults with type 1 diabetes (T1D), results of a 15-year cohort study suggest.

Waist-height ratio predicts severe diabetic eye disease risk in T1D

08 Feb 2022

Esmethadone clears phase II trial as adjunctive treatment for major depressive disorder

REL-1017 (esmethadone), a novel N-methyl-D-aspartate receptor channel blocker, demonstrates favourable safety, tolerability, and pharmacokinetic profiles and appears to have rapid and sustained antidepressant effects relative to placebo in major depressive disorder patients with inadequate responses to antidepressant treatments, according to a recent study.

Esmethadone clears phase II trial as adjunctive treatment for major depressive disorder

Apatinib a new treatment alternative for thyroid cancer?

In individuals with progressive locally advanced or metastatic radioactive iodine-refractory differentiated thyroid cancer (RAIR-DTC), the VEGFR-2* inhibitor apatinib demonstrated significant clinical benefits in terms of progression-free survival (PFS) and overall survival (OS), with a manageable safety profile, findings from the phase III REALITY trial suggest.

Apatinib a new treatment alternative for thyroid cancer?